★ Important
national
U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma
A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
Read full article at source ↗Related news
India's Got Latent: FIRs Against Samay Raina Over Insensitive Remarks Cancelled By Top Court
From Rs 37,000 Per Month To Over Rs 2 Crore Package In 11 Years: Techie Shares His Journey
SNAP Registration 2026 To Begin Soon: Check Eligibility, Courses And Other Details
Kerala launches My Police Station project to enhance citizen-friendly services
‘Deeply flawed approach’: Bar Council’s NALSAR enrolment U-turn draws criticism from ABVP
Caste Census 2027: Full list of questions to be asked in the second phase of Census
"I Am Not Afraid": Sukhbir Badal's First Statement After Attack In Maharashtra's Nanded
Independence Day 2026: Where am I from? The complicated meaning of home for Indians abroad